Benitec Biopharma Debt 2024

Benitec Biopharma Aktienanalyse

What does Benitec Biopharma do?

Benitec Biopharma Inc is a biopharmaceutical company based in the United States that focuses on developing groundbreaking therapies for the treatment of serious diseases. The company was founded in 1995 and is headquartered in Hayward, California. Benitec Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Benitec Biopharma's Debt Structure

Benitec Biopharma's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Benitec Biopharma's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Benitec Biopharma’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Benitec Biopharma’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Benitec Biopharma stock

What is the debt of Benitec Biopharma this year?

Benitec Biopharma has a debt level of -2.48 USD this year.

What was the debt of Benitec Biopharma compared to the previous year?

The debt of Benitec Biopharma has increased by -38.92% compared to the previous year dropped.

What are the consequences of high debt for investors in Benitec Biopharma?

High debt can pose a risk for investors of Benitec Biopharma, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Benitec Biopharma?

Low debt means that Benitec Biopharma has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Benitec Biopharma affect the company?

An increase in debt of Benitec Biopharma can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Benitec Biopharma affect the company?

A reduction in debt of Benitec Biopharma can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Benitec Biopharma?

Some factors that can influence the debt of Benitec Biopharma include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Benitec Biopharma so important for investors?

The debts of Benitec Biopharma are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Benitec Biopharma take to change the debt?

To change the debt, Benitec Biopharma can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Benitec Biopharma pay?

Over the past 12 months, Benitec Biopharma paid a dividend of 0.04 USD . This corresponds to a dividend yield of about 0.47 %. For the coming 12 months, Benitec Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Benitec Biopharma?

The current dividend yield of Benitec Biopharma is 0.47 %.

When does Benitec Biopharma pay dividends?

Benitec Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Benitec Biopharma?

Benitec Biopharma paid dividends every year for the past 0 years.

What is the dividend of Benitec Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Benitec Biopharma located?

Benitec Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Benitec Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Benitec Biopharma from 6/8/2018 amounting to 0.003 USD, you needed to have the stock in your portfolio before the ex-date on 6/1/2018.

When did Benitec Biopharma pay the last dividend?

The last dividend was paid out on 6/8/2018.

What was the dividend of Benitec Biopharma in the year 2023?

In the year 2023, Benitec Biopharma distributed 0 USD as dividends.

In which currency does Benitec Biopharma pay out the dividend?

The dividends of Benitec Biopharma are distributed in USD.